欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号MT/H/0335/001
药品名称Letrozole 2.5 mg tablets
活性成分
    • Letrozole 2.5 mg
剂型Film-coated tablet
上市许可持有人Accord Healthcare Ireland Limited 7-8 Euro House, Euro Business Park, Little Island, Co. Cork, T45K857, Ireland
参考成员国 - 产品名称Malta (MT)
Letrozole 2.5mg Film-Coated Tablets
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 20075/0076 - 0014
    • Lithuania (LT)
      Letrozole Accord 1 mg plėvele dengtos tabletės
    • Estonia (EE)
      LETROZOLE ACCORD
    • Poland (PL)
    • Cyprus (CY)
      Letrozole Accord 2.5 mg tablets
    • Romania (RO)
      Letrozol Accord 2,5 mg comprimate filmate
许可日期2008/09/09
最近更新日期2024/10/29
药物ATC编码
    • L02BG04 letrozole
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase